There is insufficient information available on the incidence and cause of death in patients with sickle cell disease in Britain. Some physicians still believe that the median expected survival in sickle cell anaemia is only 20 years, as calculated by Scott in 1970 SS, 7 suggests that at least 28-6% of the deaths in SS were sudden. Death from sickle cell disease seems most often to be related to pulmonary complications which include acute chest syndrome, infection, and pulmonary embolism. In infants under two years of age, however, the Jamaican series showed acute splenic sequestration-frequently associated with pneumococcal infection-to be marginally more common, causing 15 of the 41 deaths compared with 13 the lungs. 0 On the other hand, the reports from Jamaica do not distinguish those cases related to pneumonia from those attributed to pulmonary embolism.7 A further source of controversy surrounds the pathogenesis of acute chest syndrome. While most authors agree that most cases are caused by ischaemic infarcts, opinions on the contribution of pulmonary embolism vary. Oppenheimer and Esterly found necropsy evidence of thromboemboli in nearly 66% of patients with sickle cell disease, noting that the prevalence increased with age." Haupt et al, however, found no significant difference in the prevalence of thromboemboli and thromboembolic infarction among 72 patients with sickle cell disease and age, sex, and racematched controls.'2 Instead, massive pulmonary emboli of necrotic bone marrow were reported in nine (13%) patients but not in controls. There was also an increased incidence of alveolar wall necrosis (17% compared with 6%).
Embolism of thrombus or necrotic bone marrow may not be the only cause of pulmonary infarction. In a careful histological examination of a single case of the acute chest syndrome Athanasou et al found multiple large pulmonary infarcts,"3 most of which had no association with thrombosis or emboli. Vascular spasm was suggested as an alternative mechanism of infarction.
In all of these studies of the acute chest syndrome the most consistent finding is the presence of intense arteriolar and capillary congestion with masses of sickled red cells. This also features in the present series but is often described as non-specific and mistakenly attributed to sickling after death or left ventricular failure. These changes were not seen in our evaluable non-pulmonary deaths (cases 2 and 3) where the lungs remained well aerated. We regard them as specific for acute chest syndrome, whatever its aetiology. Mortality can only be reliably assessed through a study of a cohort of children with sickle cell disease followed up from birth, as has been elegantly shown by Serjeant in Jamaica.6 7 In Britain few district health authorities have adopted neonatal screening programmes for sickle haemoglobinopathies. The screening in Brent was started in 1981 and a regional programme is now being introduced for all births in the North West Thames Region. Even with the whole region systematically screened only about 25 babies with sickle cell disease are likely to be born every year-a number too small to provide reliable mortality figures in the short term. A cooperative study of all babies diagnosed at birth in Britain and the more widespread acceptance of neonatal screening would help to clarify the situation more rapidly. A further argument for such a policy is that a high proportion of children with sickle cell disease die with the initial symptoms of their disease. '6 If not screened at birth these children will not be diagnosed and their deaths will be unavoidable.
The cause of death was evaluable in 16 of our 18 cases. One death (case 9) may not have been preventable, but in almost all of the remaining cases death might have been prevented by improved antibiotic prophylaxis, perioperative care, and earlier intervention, even though 10 of the 18 cases died at home. The Cooperative Study of Sickle Cell Disease in the USA showed a 3-3% infant death rate in 600 such children enrolled before 6 months ofage. 7 This is lower than the previously reported mortality and is accounted for by early diagnosis of sickle cell disease, successful treatment of pneumococcal septicaemia, immunisation, and improved nutrition, education and health care.18
The importance of continuing education of patients and their families as well as medical and nursing staff cannot be over-emphasised. As no major innovations can be seen in the management of sickle cell disease early diagnosis and the identification of preventable causes of death remain the most likely means of reducing the death rate in this disease.
